Application of lupenone to preparation of drug for prevention and/or treatment of senile dementia and preparation
A technology of lupenone and senile dementia, applied in preparations, the application field of lupenone in the preparation of drugs for the prevention and/or treatment of senile dementia, which can solve the problems of many side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] 1. Lupenone on Aβ 25-35 Improvement of protein-induced symptoms in senile dementia mice
[0027] 1.1 Experimental animals and reagents
[0028] Experimental animals: 50 clean-grade healthy male Kunming mice, weighing 26-30 g, were purchased from the Comparative Medicine Center of Yangzhou University. Reagent: lupenone (purity is 91%), provided by Jiangsu Kangyuan Pharmaceutical Co., Ltd.; Aβ 25-35 Purchased from sigma company; ChAT and AchE detection kits were purchased from Nanjing Jiancheng Bioengineering Institute; Naofukang was purchased from Hubei Huazhong Pharmaceutical Co., Ltd.
[0029] 1.2 Condensed Aβ 25-35 preparation of
[0030] 1mgAβ 25-35 Dissolve in 943μl sterilized physiological saline at a concentration of 1mmol / L, seal it and place it in a 37℃ cell culture incubator for 5-7d incubation to make it into condensed Aβ 25-35 , placed in a -20°C freezer for later use.
[0031] 1.3 Preparation and administration of mouse AD model
[0032] After the mi...
Embodiment 2
[0053] 2. Effect of lupenone on D-galactose and AlCl 3 Protective effect of induced compound senile dementia in rats
[0054] 2.1 Experimental animals and reagents
[0055] Experimental animals: aged healthy male Wistar rats, weighing 350-390 g, a total of 75 were purchased from the Comparative Medicine Center of Yangzhou University. Reagent: lupenone (purity is 91%), provided by Jiangsu Kangyuan Pharmaceutical Co., Ltd.; D-galactose, AlCl 3 Bought from Sinopharm Chemical Reagent Co., Ltd.; SOD, MDA, and CAT activity detection kits were purchased from Nanjing Jiancheng Bioengineering Research Institute; Naofukang was purchased from Hubei Huazhong Pharmaceutical Co., Ltd.
[0056] 2.2 Preparation and administration of compound senile dementia animal model
[0057] Experimental Wistar rats were randomly divided into control group, model group, Naofukang group, lupenone I group, and lupenone II group, with 15 rats in each group. The model group and the treatment group were gi...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
